Jump to ContentJump to Main Navigation

Reviews in the Neurosciences

Editor-in-Chief: Huston, Joseph P.

Editorial Board Member: Topic, Bianca / Adeli, Hojjat / Buzsaki, Gyorgy / Crawley, Jacqueline / Crow, Tim / Eichenbaum, Howard / Gold, Paul / Holsboer, Florian / Korth, Carsten / Lubec, Gert / McEwen, Bruce / Pan, Weihong / Pletnikov, Mikhail / Robbins, Trevor / Schnitzler, Alfons / Stevens, Charles / Steward, Oswald / Trojanowski, John

6 Issues per year

increased IMPACT FACTOR 2013: 3.314
Rank 105 out of 251 in category Neurosciences in the 2013 Thomson Reuters Journal Citation Report/Science Edition

VolumeIssuePage

Issues

Inducible pluripotent stem cells for the treatment of ischemic stroke: current status and problems

Yu Zhu1 / Shu Wan1 / 1

1Department of Neurosurgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China

Corresponding author: Ren-ya Zhan, Department of Neurosurgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China

Citation Information: . Volume 23, Issue 4, Pages 393–402, ISSN (Online) 2191-0200, ISSN (Print) 0334-1763, DOI: 10.1515/revneuro-2012-0042, June 2012

Publication History

Received:
2012-04-02
Accepted:
2012-05-04
Published Online:
2012-06-24

Abstract

Despite dramatic advancements in medical and surgical care, effective clinical therapies for ischemic stroke are limited. Stem-cell transplantation has emerged as a potential therapeutic approach for cell replacement in ischemic brain injuries. Inducible pluripotent stem cells (iPSCs) have become an alternative cell source for transplantation. They possess efficient capacities for neural differentiation without ethical and immune-rejection concerns. Substantial function of iPSCs in pre-clinical models of ischemic brain injury has been observed. However, several problems remain regarding the treatment of ischemic stroke with iPSCs: tumorigenicity, poor iPSC derivation methods, and undefined delivery variables. With the development of iPSC research, safer and more effective strategies will be achieved for highly effective and tumor-free cell treatment of ischemic stroke.

Keywords: inducible pluripotent stem cell; ischemic stroke; neural differentiation; stem cell transplantation; tumorigenicity

Comments (0)

Please log in or register to comment.
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.